國立成功大學 |
2023 |
Real-World Evidence of Effectiveness and Safety of Vedolizumab for Inflammatory Bowel Disease inTaiwan: A Prospective Nationwide Registry (VIOLET) Study
|
Lin, W.-C.;Tai, W.-C.;Chang, Chang C.-H.;Tu, C.-H.;Feng, I.-C.;Shieh, M.-J.;Chung, Chung C.-S.;Yen, H.-H.;Chou, J.-W.;Wong, J.-M.;Liu, Y.-H.;Huang, T.-Y.;Chuang, Chuang C.-H.;Tsai, Tsai T.-J.;Chiang, F.-F.;Lu, C.-Y.;Hsu, W.-H.;Yu, F.-J.;Chao, T.-H.;Wu, D.-C.;Ho, A.-S.;Lin, H.-H.;Feng, C.-L.;Wu, K.-L.;Wong, M.-W.;Tung, C.-C.;Lin, C.-C.;Chen, Chen C.-C.;Hu, Hu H.-M.;Lu, Lu L.-S.;Wang, H.-S.;Wu, I.-C.;Kuo, H.-Y.;Wu, J.-F.;Shih, H.Y.;Ni, Y.-H.;Tang, S.-L.;Chen, P.-H.;Wei, S.-C. |
臺大學術典藏 |
2022-03-10T05:59:39Z |
Prostaglandin reductase 2 modulates ros-mediated cell death and tumor transformation of gastric cancer cells and is associated with higher mortality in gastric cancer patients
|
Yun-Chia Chang E.; Tsai S.-H.; Shun C.-T.; Hee S.-W.; YI-CHENG CHANG; Tsai Y.-C.; Tsai J.-S.; Chen H.-J.; Chou J.-W.; Lin S.-Y.; Chuang L.-M. |
臺大學術典藏 |
2021-06-15T03:12:05Z |
Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients
|
Lin W.-C.; Wong J.-M.; Tung C.-C.; Lin C.-P.; Chou J.-W.; Wang H.-Y.; Shieh M.-J.; Chang C.-H.; Liu H.-H.; SHU-CHEN WEI; Taiwan Society of Inflammatory Bowel Disease Multicenter Study |
臺大學術典藏 |
2021-06-15T03:12:02Z |
Management of Crohn's disease in Taiwan: Consensus guideline of the Taiwan society of inflammatory bowel disease
|
SHU-CHEN WEI; Chang T.-A.; Chao T.-H.; Chen J.-S.; Chou J.-W.; Chou Y.-H.; Chuang C.-H.; Hsu W.-H.; Huang T.-Y.; Hsu T.-C.; Lin C.-C.; Lin H.-H.; Lin J.-K.; Lin W.-C.; Ni Y.-H.; Shieh M.-J.; Shih I.-L.; Shun C.-T.; Tsang Y.-M.; Wang C.-Y.; Wang H.-Y.; Weng M.-T.; Wu D.-C.; Wu W.-C.; Yen H.-H.; Wong J.-M. |
臺大學術典藏 |
2021-06-15T03:12:01Z |
Management of ulcerative colitis in Taiwan: Consensus guideline of the Taiwan Society of inflammatory bowel disease
|
SHU-CHEN WEI; Chang T.-A.; Chao T.-H.; Chen J.-S.; Chou J.-W.; Chou Y.-H.; Chuang C.-H.; Hsu W.-H.; Huang T.-Y.; Hsu T.-C.; Lin C.-C.; Lin H.-H.; Lin J.-K.; Lin W.-C.; Ni Y.-H.; Shieh M.-J.; Shih I.-L.; Shun C.-T.; Tsang Y.-M.; Wang C.-Y.; Wang H.-Y.; Weng M.-T.; Wu D.-C.; Wu W.-C.; Yen H.-H.; Wong J.-M. |
臺大學術典藏 |
2021-06-15T03:12:01Z |
Outcomes of limited period of adalimumab treatment in moderate to severe Crohn's disease patients: Taiwan Society of Inflammatory Bowel Disease Study
|
Lin W.-C.; Chou J.-W.; Yen H.-H.; Hsu W.-H.; Lin H.-H.; Lin J.-K.; Chuang C.-H.; Huang T.-Y.; Wang H.-Y.; SHU-CHEN WEI; Wong J.-M. |
臺大學術典藏 |
2021-06-15T03:12:00Z |
Balloon-assisted enteroscopy and capsule endoscopy in suspected small bowel Crohn’s disease
|
Yen H.-H.; Chang C.-W.; Chou J.-W.; SHU-CHEN WEI |
臺大學術典藏 |
2021-03-18T02:02:51Z |
Prostaglandin reductase 2 modulates ros-mediated cell death and tumor transformation of gastric cancer cells and is associated with higher mortality in gastric cancer patients
|
Yun-Chia Chang E.; Tsai S.-H.; CHIA-TUNG SHUN; Hee S.-W.; Chang Y.-C.; Tsai Y.-C.; Tsai J.-S.; Chen H.-J.; Chou J.-W.; Lin S.-Y.; Chuang L.-M. |
臺大學術典藏 |
2021-03-18T02:02:34Z |
Management of Crohn's disease in Taiwan: Consensus guideline of the Taiwan society of inflammatory bowel disease
|
Wei S.-C.;Chang T.-A.;Chao T.-H.;Chen J.-S.;Chou J.-W.;Chou Y.-H.;Chuang C.-H.;Hsu W.-H.;Huang T.-Y.;Hsu T.-C.;Lin C.-C.;Lin H.-H.;Lin J.-K.;Lin W.-C.;Ni Y.-H.;Shieh M.-J.;Shih I.-L.;Chia-Tung Shun;Tsang Y.-M.;Wang C.-Y.;Wang H.-Y.;Weng M.-T.;Wu D.-C.;Wu W.-C.;Yen H.-H.;Wong J.-M.; Wei S.-C.; Chang T.-A.; Chao T.-H.; Chen J.-S.; Chou J.-W.; Chou Y.-H.; Chuang C.-H.; Hsu W.-H.; Huang T.-Y.; Hsu T.-C.; Lin C.-C.; Lin H.-H.; Lin J.-K.; Lin W.-C.; Ni Y.-H.; Shieh M.-J.; Shih I.-L.; CHIA-TUNG SHUN; Tsang Y.-M.; Wang C.-Y.; Wang H.-Y.; Weng M.-T.; Wu D.-C.; Wu W.-C.; Yen H.-H.; Wong J.-M. |
臺大學術典藏 |
2021-03-18T02:02:33Z |
Management of ulcerative colitis in Taiwan: Consensus guideline of the Taiwan Society of inflammatory bowel disease
|
Wei S.-C.;Chang T.-A.;Chao T.-H.;Chen J.-S.;Chou J.-W.;Chou Y.-H.;Chuang C.-H.;Hsu W.-H.;Huang T.-Y.;Hsu T.-C.;Lin C.-C.;Lin H.-H.;Lin J.-K.;Lin W.-C.;Ni Y.-H.;Shieh M.-J.;Shih I.-L.;Chia-Tung Shun;Tsang Y.-M.;Wang C.-Y.;Wang H.-Y.;Weng M.-T.;Wu D.-C.;Wu W.-C.;Yen H.-H.;Wong J.-M.; Wei S.-C.; Chang T.-A.; Chao T.-H.; Chen J.-S.; Chou J.-W.; Chou Y.-H.; Chuang C.-H.; Hsu W.-H.; Huang T.-Y.; Hsu T.-C.; Lin C.-C.; Lin H.-H.; Lin J.-K.; Lin W.-C.; Ni Y.-H.; Shieh M.-J.; Shih I.-L.; CHIA-TUNG SHUN; Tsang Y.-M.; Wang C.-Y.; Wang H.-Y.; Weng M.-T.; Wu D.-C.; Wu W.-C.; Yen H.-H.; Wong J.-M. |
臺大學術典藏 |
2021-02-03T05:42:17Z |
Endoscopic management of strictures in patients with Crohn's disease - A multi-center experience in Taiwan
|
Chang C.-W.; CHIA-HUNG TU; Chou J.-W.; Huang T.-Y.; Hsu W.-H.; Wang Y.-P.; Chen C.-C.; Chung C.-S.; Lin C.-P.; Lin W.-C.; Tai C.-M.; Wang H.-Y.; Chen M.-J. |
國立成功大學 |
2021 |
First-Principles Study of C-C Coupling Pathways for CO2Electrochemical Reduction Catalyzed by Cu(110)
|
Kuo, T.-C.;Chou, J.-W.;Shen, M.-H.;Hong, Z.-S.;Chao, T.-H.;Lu, Q.;Cheng, M.-J. |
臺大學術典藏 |
2020-12-28T08:14:15Z |
Management of ulcerative colitis in Taiwan: Consensus guideline of the Taiwan Society of inflammatory bowel disease
|
Lin J.-K.; Lin W.-C.; Lin H.-H.; Lin C.-C.; Hsu T.-C.; Huang T.-Y.; Wei S.-C.; Chang T.-A.; Chao T.-H.; Chen J.-S.; Chou J.-W.; Chou Y.-H.; Chuang C.-H.; Hsu W.-H.; YEN-HSUAN NI; Shieh M.-J.; Shih I.-L.; Shun C.-T.; Tsang Y.-M.; Wang C.-Y.; Wang H.-Y.; Weng M.-T.; Wu D.-C.; Wu W.-C.; Yen H.-H.; Wong J.-M. |
臺大學術典藏 |
2020-12-28T08:14:15Z |
Management of Crohn's disease in Taiwan: Consensus guideline of the Taiwan society of inflammatory bowel disease
|
Lin J.-K.; Lin W.-C.; YEN-HSUAN NI; Shieh M.-J.; Shih I.-L.; Shun C.-T.; Tsang Y.-M.; Wang C.-Y.; Wang H.-Y.; Weng M.-T.; Wu D.-C.; Wu W.-C.; Yen H.-H.; Wong J.-M.; Wei S.-C.; Chang T.-A.; Chao T.-H.; Chen J.-S.; Chou J.-W.; Chou Y.-H.; Chuang C.-H.; Hsu W.-H.; Huang T.-Y.; Hsu T.-C.; Lin C.-C.; Lin H.-H. |
臺大學術典藏 |
2020-12-15T06:30:02Z |
Prostaglandin reductase 2 modulates ros-mediated cell death and tumor transformation of gastric cancer cells and is associated with higher mortality in gastric cancer patients
|
Yun-Chia Chang E.; Tsai S.-H.; Shun C.-T.; Hee S.-W.; Chang Y.-C.; Tsai Y.-C.; JAW-SHIUN TSAI; Chen H.-J.; Chou J.-W.; Lin S.-Y.; Chuang L.-M. |
臺大學術典藏 |
2020-10-14T07:24:40Z |
Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients
|
Liu H.-H.; Chang C.-H.; Shieh M.-J.; Wang H.-Y.; Chou J.-W.; Lin C.-P.; Wong J.-M.; Tung C.-C.; Lin W.-C.; Taiwan Society of Inflammatory Bowel Disease Multicenter Study; SHU-CHEN WEI |
臺大學術典藏 |
2020-10-14T07:24:37Z |
Management of Crohn's disease in Taiwan: Consensus guideline of the Taiwan society of inflammatory bowel disease
|
Hsu T.-C.; SHU-CHEN WEI; Chang T.-A.; Chao T.-H.; Chen J.-S.; Chou J.-W.; Chou Y.-H.; Chuang C.-H.; Hsu W.-H.; Huang T.-Y.; Weng M.-T.; Lin C.-C.; Lin H.-H.; Lin J.-K.; Lin W.-C.; Ni Y.-H.; Shieh M.-J.; Shih I.-L.; Shun C.-T.; Tsang Y.-M.; Wang C.-Y.; Wang H.-Y.; Wu D.-C.; Wu W.-C.; Yen H.-H.; Wong J.-M. |
臺大學術典藏 |
2020-10-14T07:24:37Z |
Outcomes of limited period of adalimumab treatment in moderate to severe Crohn's disease patients: Taiwan Society of Inflammatory Bowel Disease Study
|
Wong J.-M.; SHU-CHEN WEI; Wang H.-Y.; Yen H.-H.; Hsu W.-H.; Lin H.-H.; Lin J.-K.; Chuang C.-H.; Huang T.-Y.; Chou J.-W.; Lin W.-C. |
臺大學術典藏 |
2020-10-14T07:24:36Z |
Balloon-assisted enteroscopy and capsule endoscopy in suspected small bowel Crohn’s disease
|
Yen H.-H.; Chang C.-W.; Chou J.-W.; SHU-CHEN WEI |
臺大學術典藏 |
2020-08-14T03:15:32Z |
Management of Crohn's disease in Taiwan: Consensus guideline of the Taiwan society of inflammatory bowel disease
|
Lin J.-K.; Lin W.-C.; Ni Y.-H.; Shieh M.-J.; I-LUN SHIH; Shun C.-T.; Tsang Y.-M.; Wang C.-Y.; Wang H.-Y.; Weng M.-T.; Wu D.-C.; Wu W.-C.; Yen H.-H.; Wong J.-M.; Lin C.-C.; Huang T.-Y.; Hsu T.-C.; Hsu W.-H.; Chuang C.-H.; Chou Y.-H.; Chou J.-W.; Chen J.-S.; Chao T.-H.; Chang T.-A.; Wei S.-C.; Wei S.-C.;Chang T.-A.;Chao T.-H.;Chen J.-S.;Chou J.-W.;Chou Y.-H.;Chuang C.-H.;Hsu W.-H.;Huang T.-Y.;Hsu T.-C.;Lin C.-C.;Lin H.-H.;Lin J.-K.;Lin W.-C.;Ni Y.-H.;Shieh M.-J.;I-Lun Shih;Shun C.-T.;Tsang Y.-M.;Wang C.-Y.;Wang H.-Y.;Weng M.-T.;Wu D.-C.;Wu W.-C.;Yen H.-H.;Wong J.-M.; Lin H.-H. |
臺大學術典藏 |
2020-05-04T08:04:53Z |
An unsupervised learning model to perform side channel attack
|
Chou, J.-W.;Chu, M.-H.;Tsai, Y.-L.;Jin, Y.;Cheng, C.-M.;Lin, S.-D.; Chou, J.-W.; Chu, M.-H.; Tsai, Y.-L.; Jin, Y.; Cheng, C.-M.; Lin, S.-D.; SHOU-DE LIN |
臺大學術典藏 |
2020-02-27T06:39:26Z |
Management of Crohn's disease in Taiwan: Consensus guideline of the Taiwan society of inflammatory bowel disease
|
Wei S.-C.;Chang T.-A.;Chao T.-H.;Chen J.-S.;Chou J.-W.;Chou Y.-H.;Chuang C.-H.;Hsu W.-H.;Huang T.-Y.;Hsu T.-C.;Lin C.-C.;Lin H.-H.;Lin J.-K.;Lin W.-C.;Ni Y.-H.;Ming-Jium Shieh;Shih I.-L.;Shun C.-T.;Tsang Y.-M.;Wang C.-Y.;Wang H.-Y.;Weng M.-T.;Wu D.-C.;Wu W.-C.;Yen H.-H.;Wong J.-M.; Wei S.-C.; Chang T.-A.; Chao T.-H.; Chen J.-S.; Chou J.-W.; Chou Y.-H.; Chuang C.-H.; Hsu W.-H.; Huang T.-Y.; Hsu T.-C.; Lin C.-C.; Lin H.-H.; Lin J.-K.; Lin W.-C.; Ni Y.-H.; MING-JIUM SHIEH; Shih I.-L.; Shun C.-T.; Tsang Y.-M.; Wang C.-Y.; Wang H.-Y.; Weng M.-T.; Wu D.-C.; Wu W.-C.; Yen H.-H.; Wong J.-M. |
臺大學術典藏 |
2020-02-27T06:39:25Z |
Management of ulcerative colitis in Taiwan: Consensus guideline of the Taiwan Society of inflammatory bowel disease
|
Wei S.-C.;Chang T.-A.;Chao T.-H.;Chen J.-S.;Chou J.-W.;Chou Y.-H.;Chuang C.-H.;Hsu W.-H.;Huang T.-Y.;Hsu T.-C.;Lin C.-C.;Lin H.-H.;Lin J.-K.;Lin W.-C.;Ni Y.-H.;Ming-Jium Shieh;Shih I.-L.;Shun C.-T.;Tsang Y.-M.;Wang C.-Y.;Wang H.-Y.;Weng M.-T.;Wu D.-C.;Wu W.-C.;Yen H.-H.;Wong J.-M.; Wei S.-C.; Chang T.-A.; Chao T.-H.; Chen J.-S.; Chou J.-W.; Chou Y.-H.; Chuang C.-H.; Hsu W.-H.; Huang T.-Y.; Hsu T.-C.; Lin C.-C.; Lin H.-H.; Lin J.-K.; Lin W.-C.; Ni Y.-H.; MING-JIUM SHIEH; Shih I.-L.; Shun C.-T.; Tsang Y.-M.; Wang C.-Y.; Wang H.-Y.; Weng M.-T.; Wu D.-C.; Wu W.-C.; Yen H.-H.; Wong J.-M. |
臺大學術典藏 |
2018-09-10T09:47:57Z |
An unsupervised learning model to perform side channel attack
|
Chou, J.-W.;Chu, M.-H.;Tsai, Y.-L.;Jin, Y.;Cheng, C.-M.;Lin, S.-D.; Chou, J.-W.; Chu, M.-H.; Tsai, Y.-L.; Jin, Y.; Cheng, C.-M.; Lin, S.-D.; CHEN-MOU CHENG; SHOU-DE LIN |
臺大學術典藏 |
2017 |
Management of ulcerative colitis in Taiwan: Consensus guideline of the Taiwan Society of inflammatory bowel disease
|
Wei S.-C.;Chang T.-A.;Chao T.-H.;Chen J.-S.;Chou J.-W.;Chou Y.-H.;Chuang C.-H.;Hsu W.-H.;Huang T.-Y.;Hsu T.-C.;Lin C.-C.;Lin H.-H.;Lin J.-K.;Lin W.-C.;Ni Y.-H.;Shieh M.-J.;I-Lun Shih;Shun C.-T.;Tsang Y.-M.;Wang C.-Y.;Wang H.-Y.;Weng M.-T.;Wu D.-C.;Wu W.-C.;Yen H.-H.;Wong J.-M.; Wei S.-C.; Chang T.-A.; Chao T.-H.; Chen J.-S.; Chou J.-W.; Chou Y.-H.; Chuang C.-H.; Hsu W.-H.; Huang T.-Y.; Hsu T.-C.; Lin C.-C.; Lin H.-H.; Lin J.-K.; Lin W.-C.; Ni Y.-H.; Shieh M.-J.; I-LUN SHIH; Shun C.-T.; Tsang Y.-M.; Wang C.-Y.; Wang H.-Y.; Weng M.-T.; Wu D.-C.; Wu W.-C.; Yen H.-H.; Wong J.-M. |
臺大學術典藏 |
2017 |
Management of ulcerative colitis in Taiwan: Consensus guideline of the Taiwan Society of inflammatory bowel disease
|
Weng M.-T.; Wu D.-C.; Wang H.-Y.; Wang C.-Y.; Tsang Y.-M.; Shun C.-T.; Shih I.-L.; Shieh M.-J.; Ni Y.-H.; Lin W.-C.; Chao T.-H.; Chen J.-S.; Chou J.-W.; Chou Y.-H.; Chuang C.-H.; Hsu W.-H.; Huang T.-Y.; Hsu T.-C.; Lin C.-C.; Lin H.-H.; Lin J.-K.; Wu W.-C.; Yen H.-H.; Wong J.-M.; SHU-CHEN WEI; Chang T.-A. |
國立成功大學 |
2017 |
Management of Crohn's disease in Taiwan: Consensus guideline of the Taiwan society of inflammatory bowel disease
|
Wei, S.-C.;Chang, T.-A.;Chao, T.-H.;Chen, J.-S.;Chou, J.-W.;Chou, Y.-H.;Chuang, Chuang C.-H.;Hsu, W.-H.;Huang, T.-Y.;Hsu, T.-C.;Lin, C.-C.;Lin, H.-H.;Lin, J.-K.;Lin, W.-C.;Ni, Y.-H.;Shieh, M.-J.;Shih, I.-L.;Shun, C.-T.;Tsang, Y.-M.;Wang, C.-Y.;Wang, H.-Y.;Weng, M.-T.;Wu, D.-C.;Wu, Wu W.-C.;Yen, H.-H.;Wong, J.-M. |
國立成功大學 |
2017 |
Outcomes of limited period of adalimumab treatment in moderate to severe Crohn's disease patients: Taiwan Society of Inflammatory Bowel Disease Study
|
Lin, W.-C.;Chou, J.-W.;Yen, H.-H.;Hsu, W.-H.;Lin, H.-H.;Lin, J.-K.;Chuang, Chuang C.-H.;Huang, T.-Y.;Wang, H.-Y.;Wei, S.-C.;Wong, J.-M. |
國立成功大學 |
2017 |
Management of ulcerative colitis in Taiwan: Consensus guideline of the Taiwan Society of inflammatory bowel disease
|
Wei, S.-C.;Chang, T.-A.;Chao, T.-H.;Chen, J.-S.;Chou, J.-W.;Chou, Y.-H.;Chuang, Chuang C.-H.;Hsu, W.-H.;Huang, T.-Y.;Hsu, T.-C.;Lin, C.-C.;Lin, H.-H.;Lin, J.-K.;Lin, W.-C.;Ni, Y.-H.;Shieh, M.-J.;Shih, I.-L.;Shun, C.-T.;Tsang, Y.-M.;Wang, C.-Y.;Wang, H.-Y.;Weng, M.-T.;Wu, D.-C.;Wu, Wu W.-C.;Yen, H.-H.;Wong, J.-M. |
臺大學術典藏 |
2015 |
Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients
|
Lin C.-P.; Chou J.-W.; Wang H.-Y.; Shieh M.-J.; Chang C.-H.; Liu H.-H.; Wei S.-C.; Taiwan Society of Inflammatory Bowel Disease Multicenter Study; Lin W.-C.; Wong J.-M.; CHIEN-CHIH TUNG |
國立交通大學 |
2014-12-08T15:09:36Z |
Fluorescence signals of core-shell quantum dots enhanced by single crystalline gold caps on silicon nanowires
|
Christiansen, S. H.; Chou, J. W.; Becker, M.; Sivakov, V.; Ehrhold, K.; Berger, A.; Chou, W. C.; Chuu, D. S.; Goesele, U. |
國立交通大學 |
2014-12-08T15:09:05Z |
Observation of localized surface plasmons in spatially controlled array structures
|
Chou, J. W.; Lin, Kao-Chin; Lee, Yao-Jen; Yuan, Chi-Tsu; Hsueh, Fu-Kuo; Shih, Hsun-Chuan; Fan, Wen-Chung; Luo, Chih-Wei; Lin, Ming-Chieh; Chou, Wu-Ching; Chuu, Der-San |
國立交通大學 |
2014-12-08T15:08:32Z |
Fluorescence signals of quantum dots influenced by spatially controlled array structures
|
Chou, J. W.; Lin, K. C.; Tang, Y. T.; Hsueh, F. K.; Lee, Yao-Jen; Luo, C. W.; Chen, Y. N.; Yuan, C. T.; Shih, Hsun-Chuan; Fan, W. C.; Lin, M. C.; Chou, W. C.; Chuu, D. S. |
國立成功大學 |
2009-10-14 |
Fluorescence signals of quantum dots influenced by spatially controlled array structures
|
Chou, J. W.; Lin, K. C.; Tang, Y. T.; Hsueh, F. K.; Lee, Yao-Jen; Luo, C. W.; Chen, Yueh-Nan; Yuan, C. T.; Shih, Hsun-Chuan; Fan, W. C.; Lin, M. C.; Chou, W. C.; Chuu, D. S. |